INFUSYSTEM HOLDINGS, INC Interest Expense Nonoperating
INFUSYSTEM HOLDINGS, INC (INFU) reported Interest Expense Nonoperating of $255.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC interest expense nonoperating for the quarter ending 2026-06-30 was $255.00K, a 31.64% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC interest expense nonoperating for the quarter ending 2026-03-31 was $255.00K, a 24.11% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC interest expense nonoperating for the quarter ending 2025-12-31 was $260.00K, a 27.98% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC interest expense nonoperating for the quarter ending 2025-09-30 was $330.00K, a 30.67% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC interest expense nonoperating for fiscal 2025 was $1.30M, a 26.90% decline from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC interest expense nonoperating for fiscal 2024 was $1.78M, a 18.11% decline from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC interest expense nonoperating for fiscal 2023 was $2.17M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $255.00K 10-Q · filed 2026-08-04 | $510.00K 10-Q · filed 2026-08-04 | $770.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $255.00K 10-Q · filed 2026-05-08 | $515.00K derived: sum of 2 quarters · filed 2026-05-08 | $845.00K derived: sum of 3 quarters · filed 2026-05-08 | $1.22M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $260.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $590.00K derived: sum of 2 quarters · filed 2026-02-27 | $963.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.30M 10-K · filed 2026-02-27 |
| 2025-09-30 | $330.00K 10-Q · filed 2025-11-04 | $703.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.04M 10-Q · filed 2025-11-04 | $1.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $373.00K 10-Q · filed 2026-08-04 | $709.00K 10-Q · filed 2026-08-04 | $1.07M derived: sum of 3 quarters · filed 2026-08-04 | $1.55M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $336.00K 10-Q · filed 2026-05-08 | $697.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.17M derived: sum of 3 quarters · filed 2026-05-08 | $1.66M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $361.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $837.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.32M derived: sum of 3 quarters · filed 2026-02-27 | $1.78M 10-K · filed 2026-02-27 |
| 2024-09-30 | $476.00K 10-Q · filed 2025-11-04 | $960.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.42M 10-Q · filed 2025-11-04 | $1.92M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $484.00K 10-Q · filed 2025-08-05 | $940.00K 10-Q · filed 2025-08-05 | $1.44M derived: sum of 3 quarters · filed 2025-08-05 | $2.01M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $456.00K 10-Q · filed 2025-05-08 | $959.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.52M derived: sum of 3 quarters · filed 2025-05-08 | $2.14M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.07M derived: sum of 2 quarters · filed 2025-03-11 | $1.69M derived: sum of 3 quarters · filed 2025-03-11 | $2.17M 10-K · filed 2025-03-11 |
| 2023-09-30 | $563.00K 10-Q · filed 2024-11-08 | $1.18M derived: sum of 2 quarters · filed 2024-11-08 | $1.67M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $620.00K 10-Q · filed 2024-08-09 | $1.10M 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |